STS and enhancement technologies: A programme for future research

Science and Technology Studies

Volumn 28, Issue 2, 2015, Pages 3-28

  Morrison, Michael ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bioethics; Biotechnology; Expectations

Indexed keywords

EID: 84939794608     PISSN: 22434690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Abraham J (2010) Pharmaceuticalization of society in context: Theoretical, empirical and health dimensions. Sociology 44(4): 603-622.
2. Academy of Medical Sciences British Academy Royal Academy of Engineering & Royal Society (2012) Human enhancement and the future of work: Report from a joint workshop hosted by the Academy of Medical Sciences, the British Academy, the Royal Academy of Engineering and the Royal Society. Available at: www.britac.ac.uk/policy/Human-enhancement.cfm (Accessed 10 November 2012).
3. Agar N (2004) Liberal eugenics: in defence of human enhancement. Oxford: Blackwell.
4. Ashcroft RE (2003) American biofutures: Ideology and utopia in the Fukuyama/ Stock debate. Journal of Medical Ethics 29: 59-62.
5. Banse G Grunwald A Hronszky I & Nelson G (eds) (2007) Assessing Societal Implications of Converging Technological Development. Berlin: Edition Sigma.
6. Baylis F & Robert JS (2004) The Inevitability of Genetic Enhancement Technologies. Bioethics 18(1): 1-26.
7. Bijker WE Pinch TJ & Hughes TP (eds) (1987) The social construction of technological systems: new directions in the sociology and history of technology. Cambridge, MA: MIT Press.
8. Birch K (2006) The Neoliberal Underpinnings of the Bioeconomy: The Ideological Discourses and Practices of Economic Competitiveness. Genomics, Society and Policy 2: 1-15.
9. Boorse C (1977) Health as a Theoretical Concept. Philosophy of Science 44(4): 542-573.
10. Borup M Brown N Konrad K & Van Lente H (2006) The Sociology of Expectations in Science and Technology. Technology Analysis & Strategic Management 18: 285-98.
11. Bostrom N (2003) Human Genetic Enhancements: a Transhumanist Perspective. The Journal of Value Enquiry 37: 493-506.
12. Brown N & Michael M (2003) A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects. Technology Analysis & Strategic Management 15(1): 3-18.
13. Brown N Rappert B & Webster A (eds) (2000) Contested Futures: A Sociology of Prospective Techno-Science. Aldershot: Ashgate.
14. Buchanan A (2009) Human Nature and Enhancement. Bioethics 23(3): 141-150.
15. Collins HM & Evans R (2002) The Third Wave of Science Studies: Studies of Expertise and Experience. Social Studies of Science 32(2): 235-96.
16. Conrad P & Potter D (2004) Human Growth Hormone and the Temptations of Biomedical Enhancement. Sociology of Health & Illness 26(2): 184-215.
17. Conrad P (2005) The Shifting Engines of Medicalization. Journal of Health and Social Behavior 46(1): 3-14.
18. Coveney CM (2010) Awakening Expectations: Exploring the Social and Ethical Issues Surrounding the Medical and Non-Medical Use of Sleep Drugs in the UK. Unpublished Doctorate. Nottingham: University of Nottingham.
19. Coveney CM (2011) Exploring Modafinil Use in Social Context. In: Pickersgill MD & Van Keulen I (eds) Sociological Reflections on Neuroscience. Bingley: Emerald, 203-228.
20. Crigger B-J (1998) As Time Goes by: An Intellectual Ethnography of Bioethics. In: De Vries R & Subedi J (eds) Bioethics and Society: Constructing the Ethical Enterprise. Upper Saddle River, N. J: Prentice Hall, 192-215.
21. Daniels N (1992) Growth Hormone Therapy for Short Stature: Can We Support the Treatment/Enhancement Distinction. Growth, Genetics and Hormones 8(1-supplement): S46-S48.
22. Daniels N (2000) Normal Functioning and the Treatment-Enhancement Distinction. Cambridge Quarterly of Healthcare Ethics 9(3): 309-322.
23. De Melo-Martin I (2005) Firing Up the Nature/Nurture Controversy: Bioethics and Genetic Determinism. Journal of Medical Ethics 31: 526-530.
24. De Vries R Turner L Orfali K & Bosk C (2006) Social Science and Bioethics: the Way Forward. Sociology of Health & Illness 28(6): 665-677.
25. Dickenson D (2013) Me Medicine vs. We Medicine: Reclaiming Biotechnology for the Common Good. New York: Columbia University Press.
26. Douglas M (1969) Purity and Danger: an Analysis of Concepts of Pollution and Taboo. Revised edition. London: Routledge & Kegan Paul.
27. Ehrlich P & Feldman M (2003) Genes and Cultures: What Creates our Behavioural Phenome? Current Anthropology 44(1): 87-107.
28. Evans JH (2002) Playing God? Human Genetic Engineering and the Rationalization of Public Bioethical Debate. Chicago, IL: University of Chicago Press.
29. Ferrari A (2008) Is It All about Human Nature? Ethical Challenges of Converging Technologies Beyond a Polarized Debate. Innovation: The European Journal of Social Science Research 21(1): 1-24.
30. Fuller S (2009) Knowledge Politics and New Converging Technologies: a Social Epistemological Perspective. Innovation: The European Journal of Social Science Research 22(1): 7-34.
31. Fuller S (2011) Humanity 2.0: What It Means to Be Human: Past, Present and Future. Basingstoke: Palgrave Macmillan.
32. Fukayama F (2002) Our Post-Human Future: Consequences of the Biotechnology Revolution. New York: Ferrar, Straus & Giroux.
33. Gardner W (1995) Can enhancement be prohibited? Journal of Medicine and Philosophy 20: 65-84.
34. Guggenheim M & Nowotny H (2003) Joy in Repetition Makes the Future Disappear: A Critical Assessment of the Present State of STS. In: Joerges B & Nowotny H (eds) Social Studies of Science and Technology: Looking Back, Ahead. Dordrecht: Kluwer, 229-58.
35. Hedgecoe AM (2004) Critical Bioethics: Beyond the Social Science Critique of Applied Ethics. Bioethics 18(2): 120-143.
36. Hogle LF (2005) Enhancement Technologies and the Body. Annual Review of Anthropology 34: 695-716.
37. Hughes JJ (2007) The struggle for a smarter world. Futures 39(8): 942-954.
38. Imber J (1998) Medical Publicity Before Bioethics: Nineteenth-Century Illustrations of Twentieth-Century Dilemmas. In: De Vries R & Subedi J (eds) Bioethics and society: constructing the ethical enterprise. Upper Saddle River, N.J: Prentice Hall, 16-37.
39. Juengst ET (1997) Can Enhancement Be Distinguished from Prevention in Genetic Medicine? Journal of Medicine and Philosophy 22(2): 125-142.
40. Juengst ET (1998) What Does Enhancement Mean? In: Parens E (ed) Enhancing Human Traits: Ethical and Social Implications. Washington, D. C.: Georgetown University Press, 29-47.
41. Jonsen AR (1998) The Birth of Bioethics. New York: Oxford University Press.
42. Kass LR (2003) Ageless Bodies, Happy Souls: Biotechnology and the Pursuit of Perfection. The New Atlantis 1 (Spring): 9-28.
43. Kaebnick GE (2009) "It's against nature". Hastings Center Report 39(1): 24-6.
44. Kelly SE (2006) Towards and Epistemological Luddism of Bioethics. Science Studies 19(1): 69-82.
45. Keulartz J Schermer M Korthals M & Swierstra T (2004) Ethics in Technological Culture: a Programmatic Proposal for a Pragmatist Approach. Science, Technology & Human Values 29(1): 3-29.
46. Kurzweil R (2005) Human 2.0. New Scientist 187(2518): 32-37.
47. Latour B (2004) Why Has Critique Run Out of Steam? From matters of Fact to Matters of Concern. Critical Inquiry 30(2): 225-48.
48. Latour B (1993) We Have Never Been Modern. Southampton: Harvester Wheatsheaf.
49. Lave R Mirowsky P & Sandells R (2010) Introduction: STS and Studies of Neoliberal Science. Social Studies of Science 40(5): 659-675.
50. Lewens T (2009) Enhancement and Human Nature: The Case of Sandel. Journal of Medical Ethics 35: 354-356.
51. MacKenzie D (1990) Inventing Accuracy: A Historical Sociology of Nuclear Missile Guidance. Cambridge, MA: MIT Press.
52. MacKenzie D & Wajcman J (eds) (1999) The Social Shaping of Technology (2nd edition). Maidenhead: Open University Press.
53. Martin PA (1999) Genes as Drugs: the Social Shaping of Gene Therapy and the Reconstruction of Genetic Disease. Sociology of Health & Illness 21(5): 517-538.
54. Mills C (2010) Editorial: Continental Philosophy and Bioethics. Bioethical Inquiry 7: 145-148.
55. Miller P & Wilsdon J (2006) Better Humans? The Politics of Human Enhancement and Life Extension. London: Demos.
56. Morrison M (2008) Beyond therapy? Investigating biomedical enhancement in the case of human growth hormone. Unpublished Doctorate. Nottingham: University of Nottingham.
57. Morrison M (2012) Promissory futures and possible pasts: The dynamics of expectations in regenerative medicine. BioSocieties 7: 3-22
58. Moynihan R Heath I & Henry D (2002) Selling Sickness: the Pharmaceutical Industry and Disease Mongering. British Medical Journal 324(7342): 886-890.
59. Nichter M & Vuckovic N (1994) Agenda for An Anthropology of Pharmaceutical Practice. Social Science & Medicine 39(11): 1509-1525.
60. Nordmann A (rapporteur) (2004) Converging Technologies: Shaping the Future of European Societies. Report of the European Commission High Level Expert Group (HLEG) on Foresighting the New Technology Wave. Available from at: ec.europa.eu/research/conferences/2004/ntw/pdf/final-report-en.pdf (Accessed 9 January 2010).
61. Nordmann A (2009) Tomorrow's People, Today's Challenge. In: Healey P & Rayner S (eds) Unnatural Selection: The Challenges of Engineering Tomorrow's People. London: Earthscan, 25-31.
62. Neely KE & Rosenfeld RG (1994) Use and Abuse of Human Growth Hormone. Annual Review of Medicine 45: 407-420.
63. Oxford English Dictionary (OED) Online. Enhance, v. Oxford University Press. Available at: www.oed.com/view/Entry/62342?redirectedFrom=enhance (Accessed 3 June 2013).
64. Parens E (1998) Is Better Always Good? The Enhancement Project. In: Parens E (ed) Enhancing Human Traits: Ethical and Social Implications. Washington, D.C.: Georgetown University Press, 1-28.
65. President's Council (US) (2003) Beyond Therapy? Biotechnology and the Pursuit of Happiness. Washington: Dana Press.
66. Rappert B (2007) Biotechnology, Security and the Search for Limits: An Inquiry into Research and Methods. Basingstoke: Palgrave Macmillan.
67. Roco MC (2008) Possibilities for Global Governance of Converging Technologies. Journal of Nanoparticle Research 10(1): 11-29.
68. Roco MC & Bainbridge WS (eds) (2003) Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science. Dordrecht: Kluwer Academic Publishers.
69. Roco MC & Bainbridge WS (2013) The New World of Discovery, Invention, and Innovation: Convergence of Knowledge, Technology, and Society. Journal of Nanoparticle Research 15(9): 1946.
70. Rosof PM (2010) In: Search of the Mommy Gene: Truth and Consequences in Behavioural Genetics. Science, Technology & Human Values 35(2): 200-243.
71. Rothman DJ (1994) The Problem with Cosmetic Psychopharmacology - Shiny Happy People. New Republic 210(7): 34-38.
72. Sabin J & Daniels N (1995) Determining 'Medical Necessity in Mental Health Practice. Hastings Center Report 24: 5-13.
73. Sandel MJ (2004) The Case Against Perfection: What's Wrong with Designer Children, Bionic Athletes, and Genetic Engineering? The Atlantic Monthly 293(3): 50-62.
74. Savulescu J (2007) Genetic Interventions and the Ethics of Enhancement of Human Beings. In: Steinbock B (ed) The Oxford Handbook of Bioethics. Oxford: Oxford University Press, 516-535.
75. Savalescu J (2009) Enhancement and Fairness (updated version). Available at: www.bep.ox.ac.uk/-data/assets/pdf-file/0019/9361/Updatedversion120308.pdf (Accessed 4 August 2014).
76. Science and Technology Options Assessment (STOA) (2006) Converging Technologies in the 21st century: Heaven, Hell or Down to Earth? Available at: www.europarl.europa.eu/stoa/cms/home/publications/studies?year=2006&q=&studies-search=Submit+Query (Accessed 5 August 2013).
77. Science and Technology Options Assessment (STOA) (2012) Making Perfect Life: European Governance Challenges in 21st Century Bio-engineering. Available at: www.europarl.europa.eu/stoa/cms/home/publications/studies?year=2012&q=&studies-search=Submit+Query (Accessed 5 August 2013).
78. Scully JL & Rehmann-Sutter C (2001) When Norms Normalize: The Case of Genetic Enhancement. Human Gene Therapy 12(1): 87-95.
79. Selin C (2008) The Sociology of the Future: Tracing Stories of Technology and Time. Sociology Compass 2: 1878-1895.
80. Sleeboom-Faulkner M (2011) Regulating cell lives in Japan: avoiding scandal and sticking to nature. New Genetics & Society 30(3): 227-240.
81. Tauer CA (1995) Human Growth Hormone: A Case Study in Treatment Priorities. Hastings Center Report 25(3 - special supplement): S18-S20.
82. Timmermans S & Berg M (2003) The Practice of Medical Technology. Sociology of Health & Illness 25(3): 97-114.
83. Twine R (2005) Constructing Critical Bioethics by Deconstructing Culture / Nature Dualism. Medicine, Healthcare and Philosophy 8: 285-295.
84. Van Lente H (1993) Promising Technology: The Dynamics of Expectations in Technological Developments. Enschede, NL: Proefschrift Universiteit Twente.
85. Wailoo K (2007) Old Story, Updated: Better Living Through Pills. New York Times 13th November 2007. Available at: www.nytimes.com/2007/11/13/health/13essa.html?-r=0 (Accessed 14 January 2014).
86. Woolgar S Coopmans C & Neyland D (2009) Does STS Mean Business? Organization 16(1): 5-30.
87. Wright R (1994) The Coverage of Happiness: When Prozac Meets Universal Coverage. New Republic 210(11): 24-29.
88. Zussman R (2000) The Contribution of Sociology to Medical Ethics. Hastings Center Report 30: 7-11.
89. DEEPEN - Deepening Ethical Engagement and Participation in Emerging Nanotechnologies. Project information available at: cordis.europa.eu/projects/rcn/84695-en.html
90. ENHANCE - Enhancing Human Capacities: Ethics, Regulation and European Policy. Project information available at: cordis.europa.eu/projects/index.cfm?fuseaction=app.details&TXT=ENHANCE&FRM=1&STP=10&SIC=&PGA=FP6&CCY=&PCY=&SRC=&LNG=en&REF=75601
91. EPOCH - Ethics in Public Policy making: The Case of Human Enhancement. Project information available at: cordis.europa.eu/projects/rcn/96892-en.html
92. ETHENTECH - Ethics of Enhancement Technology. Project information available at: cordis.europa.eu/projects/rcn/92742-en.html
93. FABRICED - French and British Contemporary Ethical Debates on Human Enhancement: Building Dialogue and Shared Vocabulary. Project information available at: cordis.europa.eu/projects/rcn/99853-en.html